Gilead Sciences Inc (NASDAQ:GILD)

103.70
Delayed Data
As of Apr 24
 -1.51 / -1.44%
Today’s Change
71.63
Today|||52-Week Range
116.83
+10.01%
Year-to-Date

Today’s Trading

Previous close105.21
Today’s open104.64
Day’s range103.60 - 105.68
Volume9,734,440
Average volume (3 months)11,733,591
Market cap$153.8B
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+306.08%
Earnings growth (this year)+18.60%
Earnings growth (next 5 years)+8.65%
Revenue growth (last year)+121.81%
P/E ratio14.1
Price/Sales5.76
Price/Book10.08

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-1.26-0.74%
BIIBBiogen-28.57-6.64%
BAXBaxter International...-0.37-0.52%
JUNOJuno Therapeutics In...-1.06-1.84%
Data as of 4:14pm ET, 04/24/2015

Financials

Last reporting dateApril 21, 2015
EPS forecast (this quarter)$2.29
Annual revenue (last year)$24.9B
Annual profit (last year)$12.1B
Net profit margin48.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John C. Martin
President &
Chief Operating Officer
John F. Milligan
Corporate headquarters
Foster City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers